148 related articles for article (PubMed ID: 18626197)
21. Antidiabetic effect of a novel non-thiazolidinedione PPAR gamma/alpha agonist on ob/ob mice.
Hu X; Feng Y; Shen Y; Zhao XF; Yu JH; Yang YS; Leng Y
Acta Pharmacol Sin; 2006 Oct; 27(10):1346-52. PubMed ID: 17007742
[TBL] [Abstract][Full Text] [Related]
22. Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary-induced obesity.
Samane S; Christon R; Dombrowski L; Turcotte S; Charrouf Z; Lavigne C; Levy E; Bachelard H; Amarouch H; Marette A; Haddad PS
Metabolism; 2009 Jul; 58(7):909-19. PubMed ID: 19394055
[TBL] [Abstract][Full Text] [Related]
23. A metabolic profile of fed and fasting genetically obese mice at 4-5 months of age.
Lombardo YB; Hron WT; Sobocinski KA; Menahan LA
Horm Metab Res; 1984 Dec; 16 Suppl 1():37-42. PubMed ID: 6532936
[TBL] [Abstract][Full Text] [Related]
24. Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice.
Chen MD; Liou SJ; Lin PY; Yang VC; Alexander PS; Lin WH
Biol Trace Elem Res; 1998 Mar; 61(3):303-11. PubMed ID: 9533568
[TBL] [Abstract][Full Text] [Related]
25. Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice.
Neyrinck AM; Possemiers S; Verstraete W; De Backer F; Cani PD; Delzenne NM
J Nutr Biochem; 2012 Jan; 23(1):51-9. PubMed ID: 21411304
[TBL] [Abstract][Full Text] [Related]
26. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
[TBL] [Abstract][Full Text] [Related]
27. PYY transgenic mice are protected against diet-induced and genetic obesity.
Boey D; Lin S; Enriquez RF; Lee NJ; Slack K; Couzens M; Baldock PA; Herzog H; Sainsbury A
Neuropeptides; 2008 Feb; 42(1):19-30. PubMed ID: 18164057
[TBL] [Abstract][Full Text] [Related]
28. Acute exercise reduces insulin resistance-induced TRB3 expression and amelioration of the hepatic production of glucose in the liver of diabetic mice.
Lima AF; Ropelle ER; Pauli JR; Cintra DE; Frederico MJ; Pinho RA; Velloso LA; De Souza CT
J Cell Physiol; 2009 Oct; 221(1):92-7. PubMed ID: 19492410
[TBL] [Abstract][Full Text] [Related]
29. Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice.
Chen WY; Chen CJ; Liu CH; Mao FC
Diabetes Obes Metab; 2009 Apr; 11(4):293-303. PubMed ID: 18721257
[TBL] [Abstract][Full Text] [Related]
30. Role of adrenal glands in the development of abnormal glucose and insulin homeostasis in genetically obese (ob/ob) mice.
Bailey CJ; Day C; Bray GA; Lipson LG; Flatt PR
Horm Metab Res; 1986 Jun; 18(6):357-60. PubMed ID: 3525360
[TBL] [Abstract][Full Text] [Related]
31. Raw vegetable food containing high cyclo (his-pro) improved insulin sensitivity and body weight control.
Song MK; Rosenthal MJ; Song AM; Yang H; Ao Y; Yamaguchi DT
Metabolism; 2005 Nov; 54(11):1480-9. PubMed ID: 16253637
[TBL] [Abstract][Full Text] [Related]
32. Resistance to high-fat diet in the female progeny of obese mice fed a control diet during the periconceptual, gestation, and lactation periods.
Gallou-Kabani C; Vigé A; Gross MS; Boileau C; Rabes JP; Fruchart-Najib J; Jais JP; Junien C
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1095-100. PubMed ID: 17164437
[TBL] [Abstract][Full Text] [Related]
33. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice.
Everard A; Lazarevic V; Derrien M; Girard M; Muccioli GG; Neyrinck AM; Possemiers S; Van Holle A; François P; de Vos WM; Delzenne NM; Schrenzel J; Cani PD
Diabetes; 2011 Nov; 60(11):2775-86. PubMed ID: 21933985
[TBL] [Abstract][Full Text] [Related]
34. Gut microbiota in obesity and metabolic disorders.
Sanz Y; Santacruz A; Gauffin P
Proc Nutr Soc; 2010 Aug; 69(3):434-41. PubMed ID: 20540826
[TBL] [Abstract][Full Text] [Related]
35. The delayed effects of antibiotics in type 2 diabetes, friend or foe?
Fu L; Qiu Y; Shen L; Cui C; Wang S; Wang S; Xie Y; Zhao X; Gao X; Ning G; Nie A; Gu Y
J Endocrinol; 2018 Aug; 238(2):137-149. PubMed ID: 29929986
[TBL] [Abstract][Full Text] [Related]
36. Improvement in adiposity with oligofructose is modified by antibiotics in obese rats.
Bomhof MR; Paul HA; Geuking MB; Eller LK; Reimer RA
FASEB J; 2016 Aug; 30(8):2720-32. PubMed ID: 27059718
[TBL] [Abstract][Full Text] [Related]
37. Gut microbiota composition and its effects on obesity and insulin resistance.
Caricilli AM; Saad MJ
Curr Opin Clin Nutr Metab Care; 2014 Jul; 17(4):312-8. PubMed ID: 24848531
[TBL] [Abstract][Full Text] [Related]
38. Immunometabolism of obesity and diabetes: microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation.
McPhee JB; Schertzer JD
Clin Sci (Lond); 2015 Dec; 129(12):1083-96. PubMed ID: 26464517
[TBL] [Abstract][Full Text] [Related]
39. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.
Vrieze A; Out C; Fuentes S; Jonker L; Reuling I; Kootte RS; van Nood E; Holleman F; Knaapen M; Romijn JA; Soeters MR; Blaak EE; Dallinga-Thie GM; Reijnders D; Ackermans MT; Serlie MJ; Knop FK; Holst JJ; van der Ley C; Kema IP; Zoetendal EG; de Vos WM; Hoekstra JB; Stroes ES; Groen AK; Nieuwdorp M
J Hepatol; 2014 Apr; 60(4):824-31. PubMed ID: 24316517
[TBL] [Abstract][Full Text] [Related]
40. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.
Cani PD; Possemiers S; Van de Wiele T; Guiot Y; Everard A; Rottier O; Geurts L; Naslain D; Neyrinck A; Lambert DM; Muccioli GG; Delzenne NM
Gut; 2009 Aug; 58(8):1091-103. PubMed ID: 19240062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
